Sunday 20 April 2014
 
»
Tag
 
»
AstraZeneca

Astra eyes $4.1bn Bristol diabetes venture stake

AstraZeneca has agreed to buy Bristol-Myers Squibb's stake in the companies' diabetes joint venture for up to $4.1 billion in a deal that will help return the group to growth, sending its shares to an new high. AstraZeneca

More…

AstraZeneca buys biotech firm for $440m

British drugmaker AstraZeneca said on Tuesday its MedImmune unit would buy biotech company Spirogen for up to $440 million to bolster its research and development pipeline in oncology.   Privately held Spirogen f

More…

Sanofi strong in emerging markets as rivals flag

French drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi

More…

Heart drug wins FDA approval

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved ticagrelor (Brilinta), a new heart disease medication, to reduce the risk of cardiovascular death and heart attacks in patients with acute coronary syndromes (ACS).&

More…

AstraZeneca heart drug wins Canada approval

Canadian regulators have approved AstraZeneca's key new heart drug Brilinta, boosting prospects for a product whose future in North America is uncertain. The green light from Health Canada means the medicine is now approved in 33 countries

More…

20pc Gerd cases ‘misdiagnosed in UAE’

Twenty per cent of the cases of gastroesophageal reflux disease (Gerd) are misdiagnosed in the UAE, said the organisers of a recent gastroenterology event in Dubai. The second annual meeting of the European Association for Gastroenterology

More…

Family Health Festival opens in Dubai

The third annual Family Health Festival endorsed by the Ministry of Health and Dubai Shopping Festival (DSF) and sponsored by AstraZeneca, officially kicked off on Saturday. Family Health Festival is a month-long series of events which bri

More…

AstraZeneca halts nerve growth drug study

British drugmaker AstraZeneca has halted studies on Medi-578, which treats nerve growth, to assess data on the product further. 'We saw a reason to put a halt to the studies to evaluate the data and ascertain a sensible path forward,&#

More…

AstraZeneca blood thinner gets EU approval

AstraZeneca's new heart medicine Brilique -- or Brilinta -- won final clearance from EU regulators on Monday, putting it on track to compete with Plavix, the world's second biggest-selling drug, next year. AstraZeneca is relying on revenue

More…

Generic copies of Nexium hit Germany

Several generic drugmakers have launched cheap copies of AstraZeneca's top-selling heartburn and ulcer treatment Nexium in Germany. A spokesman said on Friday the Anglo-Swedish company was aware that copycat versions of Nexium had arrived

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads

Buy high quality China wholesale Health & Beauty , Electronics, Sports & Outdoors , Computers, Video Games, Toys & Hobbies Cell Phones, Automobiles and other wholesale products directly from reliable Chinese wholesalers or Factories on DHgate.com